Knowledge Center

Patent / Jan 01, 1973

Betamethasone 21-sulfate and 21-phosphate

Authors:
  • Ivan Villax
Source:
US 3773803

The title esters were prepd. by reaction of the 21,21-diiodo deriv. with H3PO4 or H2SO4 or their salts in acid soln. Thus, 21,21-diiodo-16.beta.-methyl-9.alpha.-fluoro-11.beta.,17.alpha.-dihydroxypregna-1,4-diene-3,20-dione was refluxed in aq. Me2CO contg. K2HPO4 and 85% H3PO4 for 3 hr to give 92.5% betamethasone 21-phosphate (I). Treating I with NaOH-MeOH (pH 10.5) led to the easily sol. di-Na salt.

Also in the Knowledge Center

Related Content

Drug Substance Development

Talented people, smart processes and cutting-edge equipment – we have the perfect formula to meet all your process development and scale-up needs.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Devices

Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more